MedTrace Logo

National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life

NCT02925338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1431

Last updated 2023-01-25

Study results available
· View outcomes & findings →

Summary

National, prospective, multicentre observational study designed for eligible patients treated with Inflectra.

Its objectives are to describe under real conditions of use, the profile of patients treated with Inflectra and the response to treatment.

Conditions

Interventions

OTHER

QOL questionaire

Health assessment questionnaire disability index for rheumatoid polyarthritis questionnaire

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-19
Primary Completion
2021-04-12
Completion
2021-04-12

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02925338 on ClinicalTrials.gov